KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Change in Accured Expenses (2022 - 2025)

Novartis Ag's Change in Accured Expenses history spans 4 years, with the latest figure at $247.0 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 152.55% to $247.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $545.0 million, a 2695.24% increase, with the full-year FY2025 number at $247.0 million, changed N/A from a year prior.
  • Change in Accured Expenses hit $247.0 million in Q4 2025 for Novartis Ag, down from $952.0 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for NVS hit a ceiling of $952.0 million in Q3 2025 and a floor of -$584.0 million in Q1 2022.
  • Historically, Change in Accured Expenses has averaged $161.4 million across 4 years, with a median of $86.5 million in 2023.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 251.35% in 2024 and later skyrocketed 152.55% in 2025.
  • Tracing NVS's Change in Accured Expenses over 4 years: stood at $498.0 million in 2022, then plummeted by 114.86% to -$74.0 million in 2023, then tumbled by 535.14% to -$470.0 million in 2024, then skyrocketed by 152.55% to $247.0 million in 2025.
  • Business Quant data shows Change in Accured Expenses for NVS at $247.0 million in Q4 2025, $952.0 million in Q3 2025, and -$184.0 million in Q1 2025.